Targeted Drug Delivery - Nanomaterials for Medical Applications - page 226

103. Geish, K. Enhanced Permeability and Retention Effect of Macromolecular Drugs in Solid
Tumors: A Royal Gate for Targeted Anticancer Medicines. J. Drug Target. 2007, 15, 457-464.
104. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K.
Regulation of Transport Pathways in Tumor Vessels: Role of Tumor Type and Microenviron-
ment. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4607-4612.
105. Jain, R. K. Delivery of Molecular and Cellular Medicine to Solid Tumors. J. Contr. Release
1998, 53, 49-67.
106. Fu, B. M.; Adamson, R. H.; Curry, F. E. Test of a Two-Pathway Model for Small-Solute
Exchange across the Capillary Wall. Am. J. Physiol. 1998, 274, H2062-H2073.
107. Meyer, D. E.; Shin, B. C.; Kong, G. A.; Dewhirst, M. W.; Chilkoti, A. Drug Targeting
Using Thermally Responsive Polymers and Local Hyperthermia. J. Contr. Release 2001,
74, 213-224.
108. Nelson, J. L.; Roeder, B. L.; Carmen, J. C.; Roloff, F.; Pitt, W. G. Ultrasonically Activated
Chemotherapeutic Drug Delivery in a Rat Model. Cancer Res. 2002, 62(24), 7280-7283.
109. Tao, W. M.; Zhang, M. A Genetic Algorithm-Based Area Coverage Approach for Controlled
Drug Delivery Using Microrobots. Nanomedicine 2005, 1, 91-100.
110. Koval, M.; Preiter, K.; Adles, C.; Stahl, P. D.; Steinberg, T. H. Size of IgG Opsonized Par-
ticles Determines Macrophage Response During Internalization. Exp. Cell Res. 1998, 242,
265-273.
111. Harashima, H.; Sakata, K.; Funato, K.; Kiwada, H. Enhanced Hepatic Uptake of Liposomes
Through Complement Activation Depending on the Size of Liposomes. Pharm. Res. 1994, 11,
402-406.
112. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-Dependent Internalization of Particles
via the Pathways of Clathrin- and Caveolae-Mediated Endocytosis. Biochem. J. 2004, 377,
159-169.
113. Vauthier, C.; Dubernet, C.; Chauvierre, C.; Brigger, I.; Couvreur, P. Drug Delivery to Resis-
tant Tumors: The Potential of Poly(alkyl cyanoacrylate) Nanoparticles. J. Controlled Release
2003, 93, 151-160.
114. Miller, D. W.; Batrakova, E. V.; Kabanov, A. V. Inhibition of Multidrug Resistance-Associated
Protein (MRP) Functional Activity with Pluronic Block Copolymers. Pharm. Res. 1999, 16,
396-401.
115. Sapra, P.; Allen, T. M. Ligand-Targeted Liposomal Anticancer Drugs. Prog. Lipid Res. 2003,
42, 439-462.
116. Mamot, C.; Drummond, D. C.; Hong, K.; Kirpotin, D. B.; Park, J. W. Liposome-Based
Approaches to Overcome Anticancer Drug Resistance. Drug Resist. Update 2003, 6, 271-279.
117. Soma, C. E.; Dubernet, C.; Bentolila, D.; Benita, S.; Couvreur, P. Reversion of Multidrug
Resistance by Co-encapsulation of Doxorubicin and Cyclosporin A in Polyalkylcyanoacrylate
Nanoparticles. Biomaterials 2000, 21, 1-7.
118. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Body Distribution of Camptothecin Solid Lipid
Nanoparticles after Oral Administration. Pharm. Res. 1999, 16, 751-757.
119. Fresta, M.; Puglisi, G.; Giammona, G.; Cavallaro, G.; Micali, N.; Furneri, P. M. Pefloxacine
Mesilate- and Ofloxacin-Loaded Polyethylcyanoacrylate Nanoparticles: Characterization of
the Colloidal Drug Carrier Formulation. J. Pharm. Sci. 1995, 84, 895-902.
120. Magenheim, B.; Levy, M. Y.; Benita, S. A New In Vitro Technique for the Evaluation of
Drug Release Profile from Colloidal Carriers-Ultrafiltration Technique at Low Pressure.
Int. J. Pharm. 1993, 94, 115-123.
121. zur MuÈhlen, A.; Mehnert, W. Drug Release and Release Mechanism of Prednisolone Loaded
Solid Lipid Nanoparticles. Pharmazie 1998, 53, 552.